As of 12/31/2024, Tracenable has captured detailed data on Gilead Sciences's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group.a
The dataset includes information on 81 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Gilead Sciences's consolidated operations.a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
Asegua Therapeutics LLCa | USA | Subsidiary | Not Specified | ||
CymaBay Therapeutics, Inc.a | USA | Subsidiary | Not Specified | ||
Forty Seven, LLCa | USA | Subsidiary | Not Specified | ||
Forty Seven Holdings, LLCa | USA | Subsidiary | Not Specified | ||
Gilead Alberta, LLCa | USA | Subsidiary | Not Specified | ||
Gilead Apollo, LLCa | USA | Subsidiary | Not Specified | ||
Gilead Biopharmaceutics US LLCa | USA | Subsidiary | Not Specified | ||
Gilead Calistoga, LLCa | USA | Subsidiary | Not Specified | ||
Gilead Connecticut, Inc.a | USA | Subsidiary | Not Specified | ||
Gilead Holdings, LLCa | USA | Subsidiary | Not Specified | ||
Gilead Pharmasset LLCa | USA | Subsidiary | Not Specified | ||
Gilead Sciences, LLCa | USA | Subsidiary | Not Specified | ||
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 81 entities. Get complete coverage in the full dataset. | |||||
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
Tracenable's group entities dataset provides geographic insights into Gilead Sciences's significant subsidiaries, revealing their location around the world.a
In total, the Gilead Sciences group includes 81 significant subsidiaries distributed across 42 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure.a
This visualization highlights the geographical distribution of Gilead Sciences's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a
In 2024, Tracenable identified that the Gilead Sciences group consisted of81 significant subsidiaries, located across 42 countries.a
This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network.a
Gilead Sciences's significant subsidiaries are primarily located in Europe and North America, which together host 74.07% of its material entities.a
This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.
Gilead Sciences exhibits a limited level of transparency concerning its corporate ownership structure.
The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance.a
Without full group hierarchy or equity details, it offers a restricted view of Gilead Sciences's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.
No. Tracenable's data does not indicate any entities registered in jurisdictions typically categorized as low-tax or offshore financial centers, suggesting that Gilead Sciences's ownership network is primarily domiciled in standard corporate jurisdictions or that Gilead Sciences does not provide full transparency on its corporate structure.a